ACON - Aclarion, Inc.

3.73
0.200   5.362%

Share volume: 882,805
Last Updated: 04-22-2026
Healthcare/Services – Health: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$3.53
0.20
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 43%
Dept financing 24%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.07%
1 Month
19.55%
3 Months
-1.84%
6 Months
-51.04%
1 Year
-51.56%
2 Year
1,223.63%
Key data
Stock price
$3.73
P/E Ratio 
0.00
DAY RANGE
$3.56 - $3.92
EPS 
-$12.55
52 WEEK RANGE
$2.34 - $12.03
52 WEEK CHANGE
-$51.18
MARKET CAP 
4.368 M
YIELD 
N/A
SHARES OUTSTANDING 
671.371 K
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
05-14-2025
BETA 
-0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$192,812
AVERAGE 30 VOLUME 
$137,561
Company detail
CEO: Brent Ness
Region: US
Website: aclarion.com
Employees: 7
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.

Recent news